rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler aurobindo pharma limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 6 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-651
Product ID 65862-651_41507ad1-b7a7-40be-aa24-60a95b60f988
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204572
Listing Expiration 2026-12-31
Marketing Start 2016-03-25

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862651
Hyphenated Format 65862-651

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA204572 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE (65862-651-05)
  • 60 CAPSULE in 1 BOTTLE (65862-651-60)
  • 10 BLISTER PACK in 1 CARTON (65862-651-78) / 10 CAPSULE in 1 BLISTER PACK (65862-651-10)
source: ndc

Packages (3)

65862-651-05 500 CAPSULE in 1 BOTTLE (65862-651-05) 65862-651-60 60 CAPSULE in 1 BOTTLE (65862-651-60) 65862-651-78 10 BLISTER PACK in 1 CARTON (65862-651-78) / 10 CAPSULE in 1 BLISTER PACK (65862-651-10)

Ingredients (1)

rivastigmine tartrate (6 mg/1)

Linked Drug Pages (1)

Rivastigmine Tartrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "41507ad1-b7a7-40be-aa24-60a95b60f988", "openfda": {"unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["c246a0e5-1e77-41ee-a7b3-384f21f2f2e0"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65862-651-05)", "package_ndc": "65862-651-05", "marketing_start_date": "20160325"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (65862-651-60)", "package_ndc": "65862-651-60", "marketing_start_date": "20160325"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (65862-651-78)  / 10 CAPSULE in 1 BLISTER PACK (65862-651-10)", "package_ndc": "65862-651-78", "marketing_start_date": "20160325"}], "brand_name": "Rivastigmine Tartrate", "product_id": "65862-651_41507ad1-b7a7-40be-aa24-60a95b60f988", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "65862-651", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "6 mg/1"}], "application_number": "ANDA204572", "marketing_category": "ANDA", "marketing_start_date": "20160325", "listing_expiration_date": "20261231"}